Study of Tislelizumab for Locally Advanced Non-Small Cell Lung Cancer Following Neoadjuvant Chemotherapy Plus Tislelizumab ± Bevacizumab and Definitive Concurrent Chemoradiation Therapy
Clinical trial NCT05468242 · RECRUITING
Trial details
- NCT number
- NCT05468242
- Sponsor
- Sun Yat-sen University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-01
- Primary completion
- 2024-12-30
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.